This study is in progress, not accepting new patients
P-BCMA-101 Tscm CAR-T Cells in the Treatment of Patients With Multiple Myeloma (MM)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Diego, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Poseida Therapeutics, Inc.
- ID
- NCT03288493
- Phase
- Phase 1/2 Multiple Myeloma Research Study
- Study Type
- Interventional
- Participants
- Expecting 220 study participants
- Last Updated